发明申请
- 专利标题： Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- 专利标题（中）： 环丙基稠合吲哚扎嗪氮芥HCV NS5B抑制剂
-
申请号： US12710527申请日： 2010-02-23
-
公开(公告)号： US20100216774A1公开(公告)日： 2010-08-26
- 发明人: John A. Bender , Kyle Eastman , John F. Kadow , Zhong Yang
- 申请人： John A. Bender , Kyle Eastman , John F. Kadow , Zhong Yang
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 主分类号： A61K31/55
- IPC分类号： A61K31/55 ; C07D223/14 ; A61P31/00
摘要：
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
公开/授权文献
- US08143244B2 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors 公开/授权日：2012-03-27
信息查询
